Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemaira in HIV-1 Disease
NCT01370018Phase 3Completed
- Sponsor
- Institute for Human Genetics and Biochemistry
- Start
- Dec 2006
- Primary completion
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alpha1-proteinase inhibitor in human immunodeficiency virus infection (HIV), sponsored by Institute for Human Genetics and Biochemistry. Started Dec 2006; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01370018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370018.